Glucagon-like peptide-1 receptor is involved in learning and neuroprotection
The DOI matches its Crossref record; 41 of the 42 references it cites were found in a registry or an index.
Abstract
Glucagon-like peptide-1 (GLP-1) is a gut peptide that, together with its receptor, GLP-1R, is expressed in the brain. Here we show that intracerebroventricular (i.c.v.) GLP-1 and [Ser(2)]exendin(1-9) (HSEGTFTSD; homologous to a conserved domain in the glucagon/GLP-1 family) enhance associative and spatial learning through GLP-1R. [Ser(2)]exendin(1-9), but not GLP-1, is also active when administered peripherally. GLP-1R-deficient mice have a phenotype characterized by a learning deficit that is restored after hippocampal Glp1r gene transfer. In addition, rats overexpressing GLP-1R in the hippocampus show improved learning and memory. GLP-1R-deficient mice also have enhanced seizure severity and neuronal injury after kainate administration, with an intermediate phenotype in heterozygotes and phenotypic correction after Glp1r gene transfer in hippocampal somatic cells. Systemic administration of [Ser(2)]exendin(1-9) in wild-type animals prevents kainate-induced apoptosis of hippocampal neurons. Brain GLP-1R represents a promising new target for both cognitive-enhancing and neuroprotective agents.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“GLP-1 is involved in cognitive brain function and learning, 98”
From GLP-1 receptor agonists and next-generation incretin-based medications: metabolic, cardiovascular, and renal benefits (2026) · cites this paper as [98]
In the citing paper
“GLP1-RAs is known for its neuroprotective action, and more recent results have emerged, showing a potential benefit in people with AD [85,86,87].”
From Treatment of Alzheimer’s Disease: Beyond Symptomatic Therapies (2023) · cites this paper as [86]
In the citing paper
“They are involved in multiple biological pathways that could be beneficial in AD including improvement of BBB integrity and vascular health, promotion of homeostasis in microglia and astrocytes, positive effects on adaptative immune cells (including natural killer cells and activated regulatory T cells), improvement of synaptic viability, and neuroprotection [17–26].”
In the citing paper
“Preclinical results in murine models treated with GLP-1RAs suggest that the potential effects of semaglutide in AD may be exerted via impact on several AD-related pathophysiologic processes including neuroinflammatory pathways, vascular and BBB integrity, reduced synaptic loss, and neuroprotection [19, 21, 23–26, 46–48];”
Citations
Cites
Modification of seizure activity by electrical stimulation: II. Motor seizure
Racine, R. J. (1972) · Electroencephalography and Clinical Neurophysiology · doi:10.1016/0013-4694(72)90177-0 · Cited by 7,171
Place navigation impaired in rats with hippocampal lesions
Morris, R. G. M., Garrud, P., Rawlins, J. N. P., & O'Keefe, J. (1982) · Nature · doi:10.1038/297681a0 · Cited by 6,340
The molecular biology of memory storage: a dialogue between genes and synapses
Kandel, E. R. (2001) · Science · doi:10.1126/science.1067020 · Cited by 3,917
A role for glucagon-like peptide-1 in the central regulation of feeding
Turton, M. D., O'Shea, D., Gunn, I., Beak, S. A., Edwards, C. M. B., Meeran, K., Choi, S. J., Taylor, G. M., Heath, M. M., Lambert, P. D., et al. (1996) · Nature · doi:10.1038/379069a0 · Cited by 1,950
Sniffing neuropeptides: A transnasal approach to the human brain
Born, J., Lange, T., Kern, W., McGregor, G. P., Bickel, U., & Fehm, H. L. (2002) · Nature Neuroscience · doi:10.1038/nn0602-849 · Cited by 1,356
Fluoro-Jade B: a high affinity fluorescent marker for the localization of neuronal degeneration
Schmued, L. C., & Hopkins, K. J. (2000) · Brain Research · doi:10.1016/s0006-8993(00)02513-0 · Cited by 1,218 · cited 1×
“Immunohistochemical comparison of the CA3 subregion of the hippocampus using Fluorojade-B, a fluorochrome stain specific for degenerating neuron”
MethodKieffer, T. J., & Francis Habener, J. (1999) · Endocrine Reviews · doi:10.1210/edrv.20.6.0385 · Cited by 1,062
Scrocchi, L. A., Brown, T. J., Maclusky, N., Brubaker, P. L., Auerbach, A. B., Joyner, A. L., & Drucker, D. J. (1996) · Nature Medicine · doi:10.1038/nm1196-1254 · Cited by 793
Self-citationEnvironmental enrichment inhibits spontaneous apoptosis, prevents seizures and is neuroprotective
Young, D., Lawlor, P. A., Leone, P., Dragunow, M., & During, M. J. (1999) · Nature Medicine · doi:10.1038/7449 · Cited by 732
Self-citationStoffers, D. A., Kieffer, T. J., Hussain, M. A., Drucker, D. J., Bonner-Weir, S., Habener, J. F., & Egan, J. M. (2000) · Diabetes · doi:10.2337/diabetes.49.5.741 · Cited by 576
Self-citation
Cited by
Items 501–600 of 859
MED13 and Glycolysis Are Conserved Modifiers of α-Synuclein-Associated Neurodegeneration
Ren, M., Yang, Y., Heng, K. H. Y., Ng, L. Y., Chong, C. Y.-Y., Ng, Y. T., Gorur-Shandilya, S., Lee, R. M. Q., Lim, K., Zhang, J., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.111852 · Cited by 25
Mattson, M. P., Perry, T., & Greig, N. H. (2003) · Nature Medicine · doi:10.1038/nm0903-1113 · Cited by 24
Mediation of cognitive function by high fat diet following stress and inflammation
Yehuda, S., Rabinovitz, S., & Mostofsky, D. I. (2005) · Nutritional Neuroscience · doi:10.1080/00268970500509972 · Cited by 28
Sasaki, K., Fujita, H., Sato, T. K., Kato, S., Takahashi, Y., Takeshita, Y., Kanda, T., Saito, T., Saido, T., Hattori, S., et al. (2024) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2024.151016 · Cited by 28
The (dys)regulation of energy storage in obesity
Levin, B. E., Geary, N., & Lutz, T. A. (2025) · Physiological Reviews · doi:10.1152/physrev.00002.2024 · Cited by 29
Glucagon-like peptide-1 receptor agonists in neurodegenerative diseases: Promises and challenges
Zhou, Z., Yi, L., Popławska-Domaszewicz, K., Chaudhuri, К. R., Jankovic, J. J., & Tan, E. K. (2025) · Pharmacological Research · doi:10.1016/j.phrs.2025.107770 · Cited by 35
Liraglutide Promotes Cortical Neurite Outgrowth via the MEK–ERK Pathway
Li, M., Li, S., & Li, Y. (2015) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-015-0193-7 · Cited by 25
Hölscher, C. (2016) · Cardiovascular Endocrinology · doi:10.1097/xce.0000000000000087 · Cited by 25
Gümüşlü, E., Çine, N., Ertan, M., Mutlu, O., Celikyurt, I. K., & Ulak, G. (2017) · Fundamental and Clinical Pharmacology · doi:10.1111/fcp.12329 · Cited by 26
Jalilzad, M., Jafari, A., & Babaei, P. (2019) · Neuropeptides · doi:10.1016/j.npep.2019.101963 · Cited by 24
Long-term functional alterations following prenatal GLP-1R activation
Graham, D. L., Madkour, H. S., Noble, B. L., Schatschneider, C. W., & Stanwood, G. D. (2021) · Neurotoxicology and Teratology · doi:10.1016/j.ntt.2021.106984 · Cited by 25
Colin, I. M., Szczepanski, L. W., Gérard, A.-C., & Elosegi, J. A. (2023) · touchREVIEWS in Endocrinology · doi:10.17925/ee.2023.19.1.16 · Cited by 29
Ishøy, P. L., Knop, F. K., Broberg, B. V., Baandrup, L., Fagerlund, B., Jørgensen, N. R., Andersen, U. B., Rostrup, E., Glenthøj, B. Y., & Ebdrup, B. H. (2014) · BMJ Open · doi:10.1136/bmjopen-2013-004158 · Cited by 24
Diabetes Therapies for Dementia
Moran, C., Callisaya, M. L., Srikanth, V. K., & Arvanitakis, Z. (2019) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-019-0973-4 · Cited by 24
The role of GLP-1 signaling in hypoglycemia due to hyperinsulinism
Danowitz, M., & De Leon, D. D. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.863184 · Cited by 23
Lecis, D., Prandi, F. R., Barone, L., Belli, M., Sergi, D., Longo, S., Muscoli, S., Romeo, F., Federici, M., Lerakis, S., et al. (2023) · Biomolecules · doi:10.3390/biom13121695 · Cited by 23
“…and animal studies have suggested that GLP-1RAs may have neurotrophic and neuroprotective effects, by reducing neuroinflammation, oxidative stress, apoptosis, and mitochondrial dysfunction and by promoting the growth and repair of neural cells, potentially enhancing cognitive functions [73–75].”
Stem cells for amyotrophic lateral sclerosis modeling and therapy: Myth or fact?
Coatti, G. C., Beccari, M. S., Olávio, T. R., Mitne‐Neto, M., Okamoto, O. K., & Zatz, M. (2015) · Cytometry Part A · doi:10.1002/cyto.a.22630 · Cited by 30
Transcriptome Analysis of the Hippocampus in Novel Rat Model of Febrile Seizures
Wang, Z., Fan, Y., Xu, J., Li, L., Heng, D., Han, S. H., Yin, J., Peng, B., Liu, W., & He, X. (2014) · PLoS ONE · doi:10.1371/journal.pone.0095237 · Cited by 26
Kutlu, M. D., Köse, S., & Akıllıoğlu, K. (2023) · Behavioural Brain Research · doi:10.1016/j.bbr.2023.114386 · Cited by 27
Liang, J., Liu, B., Dong, X., Wang, Y., Cai, W., Zhang, N., & Zhang, H. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1242254 · Cited by 29
Moon, M. J., Kim, H. Y., Park, S., Kim, D.-K., Cho, E. B., Park, C. R., You, D., Hwang, J., Kim, K., Choe, H., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.276808 · Cited by 23
MOLECULAR EVOLUTION OF GPCRS: GLP1/GLP1 receptors
Hwang, J., Yun, S., Moon, M. J., Park, C. R., & Seong, J. Y. (2014) · Journal of Molecular Endocrinology · doi:10.1530/jme-13-0137 · Cited by 26
Compensatory enhancement of input maintains aversive dopaminergic reinforcement in hungry Drosophila
Meschi, E., Duquenoy, L., Otto, N., Dempsey, G., & Waddell, S. (2024) · Neuron · doi:10.1016/j.neuron.2024.04.035 · Cited by 27
Daniele, G., Campi, B., Saba, A., Codini, S., Ciccarone, A., Giusti, L., Prato, S. D., ESTERLINE, R. L., & Ferrannini, E. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00216 · Cited by 22
Longwell, C. K., Hanna, S., Hartrampf, N., Sperberg, R. A. P., Huang, P., Pentelute, B. L., & Cochran, J. R. (2020) · ACS Chemical Biology · doi:10.1021/acschembio.0c00722 · Cited by 22
Type 2 diabetes mellitus/obesity drugs: A neurodegenerative disorders savior or a bridge too far?
Kopp, K. O., Glotfelty, E. J., Li, Y., Lahiri, D. K., & Greig, N. H. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102343 · Cited by 24
Luciani, P., Deledda, C., Benvenuti, S., Squecco, R., Cellai, I., Fibbi, B., Marone, I. M., Giuliani, C., Modi, G., Francini, F., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0071716 · Cited by 23
Gargantini, E., Lazzari, L., Settanni, F., Taliano, M., Trovato, L., Gesmundo, I., Ghigo, E., & Granata, R. (2015) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2015.11.008 · Cited by 25
Possible role of DPP4 inhibitors to promote hippocampal neurogenesis in Alzheimer’s disease
Chalichem, N. S. S., Pindiprolu, S. K. S. S., & Basavan, D. (2018) · Journal of drug targeting · doi:10.1080/1061186x.2018.1433682 · Cited by 23
Incretin-Based Therapy and Type 2 Diabetes
Hare, K. J., & Knop, F. K. (2010) · Vitamins and hormones · doi:10.1016/b978-0-12-381517-0.00015-1 · Cited by 24
Hölscher, C. (2025) · CNS Drugs · doi:10.1007/s40263-025-01226-z · Cited by 30
Jo, D., Yoon, G., & Song, J. (2021) · Antioxidants · doi:10.3390/antiox10010078 · Cited by 25
Eren, C. Y., Kara, B., Sancak, S., Uysal, S. P., Yazıcı, D., Okuroğlu, N., Whitton, A. E., Rutherford, A. V., & Eser, H. Y. (2021) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000001409 · Cited by 23
Erdoğan, M. A., Erdoğan, A., & Erbaş, O. (2022) · Neurochemical Research · doi:10.1007/s11064-022-03736-4 · Cited by 28
Intranasal glucagon for hypoglycaemia in diabetic patients. An old dream is becoming reality?
Pontiroli, A. E., & Ceriani, V. (2018) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13317 · Cited by 22
Aljanabi, N. M., Mamtani, S. S., Al-Ghuraibawi, M. M. H., Yadav, S. K., & Nasr, L. A. (2020) · Cureus · doi:10.7759/cureus.6885 · Cited by 25
Chaudhari, S. K., Shotorbani, P. Y., Tao, Y., Davis, M. E., Mallet, R. T., & Ma, R. (2020) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00043.2020 · Cited by 22
Keshava, H. B., Mowla, A., Heinberg, L. J., Schauer, P. R., Brethauer, S. A., & Aminian, A. (2017) · Medical Hypotheses · doi:10.1016/j.mehy.2017.05.002 · Cited by 22
Nance, K. D., Days, E., Weaver, C. D., Coldren, A., Farmer, T. D., Cho, H. P., Niswender, C. M., Blobaum, A. L., Niswender, K. D., & Lindsley, C. W. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b01706 · Cited by 22
Novelle, M. G., & Diéguez, C. (2018) · European Eating Disorders Review · doi:10.1002/erv.2641 · Cited by 22
Safar, M. M., Shahin, N. N., Mohamed, A. F., & Abdelkader, N. F. (2020) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2020.109144 · Cited by 21
Listos, J., Listos, P., Baranowska-Bosiacka, I., Karpiuk, A., Filarowska, J., Łupina, M., Słowik, T., Zawiślak, S., & Kotlińska, J. (2022) · Molecules · doi:10.3390/molecules27082478 · Cited by 20
Recent achievements and future directions of anti-obesity medications
Grandl, G., Novikoff, A., Liu, X., & Müller, T. D. (2024) · The Lancet Regional Health - Europe · doi:10.1016/j.lanepe.2024.101100 · Cited by 32
McIntyre, R. S., Vagic, D., Swartz, S. A., Soczynska, J. K., Woldeyohannes, H. O., Voruganti, L. P., & Konarski, J. Z. (2008) · CNS Drugs · doi:10.2165/00023210-200822060-00001 · Cited by 21
Liraglutide attenuates partial warm ischemia-reperfusion injury in rat livers
Abdelsameea, A. A., Abbas, N. A. T., & Raouf, S. M. A.-E. (2016) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-016-1330-7 · Cited by 23
Smith, K., Moran, T. H., Papantoni, A., Speck, C. L., Bakker, A., Kamath, V. J., Carnell, S., & Steele, K. E. (2019) · Surgical Endoscopy · doi:10.1007/s00464-019-07015-2 · Cited by 21
Antisecretory factor modulates GABAergic transmission in the rat hippocampus
Kim, M., Wasling, P., Xiao, M., Jennische, E., Lange, S., & Hanse, E. (2005) · Regulatory Peptides · doi:10.1016/j.regpep.2005.01.018 · Cited by 23
The GLP‐1 system as a therapeutic target
Edwards, M. C. B. (2005) · Annals of Medicine · doi:10.1080/07853890510037400 · Cited by 19
Incretin-based therapeutics for the treatment of neurodegenerative diseases
Vear, A., Heneka, M. T., & Clemmensen, C. (2025) · Nature Metabolism · doi:10.1038/s42255-025-01263-4 · Cited by 26
Non-glucose risk factors in the pathogenesis of diabetic peripheral neuropathy
Lee, K. A., Park, T. S., & Jin, H. Y. (2020) · Endocrine · doi:10.1007/s12020-020-02473-4 · Cited by 20
Nakamura, M., Samii, A., Lang, J. M., Götz, F., Samii, M., & Krauss, J. K. (2015) · Neurosurgery · doi:10.1227/neu.0000000000001025 · Cited by 19
Olukorode, J., Orimoloye, D. A., Nwachukwu, N. O., ONWUZO, C. N., Oloyede, P. O., Fayemi, T., Odunaike, O. S., Ayobami-Ojo, P. S., Divine, N., Alo, D. J., et al. (2024) · Cureus · doi:10.7759/cureus.72080 · Cited by 42
Albiglutide: Is a better hope against diabetes mellitus?
Sharma, A. K., Veeraveedu, P. T., & Rajput, S. K. (2015) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2015.12.015 · Cited by 19
Russo, C., Russo, A., Pellitteri, R., & Stanzani, S. (2017) · Neuroscience Letters · doi:10.1016/j.neulet.2017.05.049 · Cited by 22
Ruze, R., Xu, Q., Liu, G., Li, Y., Chen, W., Cheng, Z., Xiong, Y., Liu, S., Zhang, G., Hu, S., et al. (2021) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00126.2021 · Cited by 20
Lee, J. Y., Park, T., Hong, E., Amatya, R., Park, K., Park, Y.-H., Min, K. A., Jin, M., Lee, S., Hwang, S., et al. (2020) · Biomaterials · doi:10.1016/j.biomaterials.2020.120250 · Cited by 19
Exendin-4 increases absence-like seizures and anxiety–depression-like behaviors in WAG/Rij rats
Aygün, H. (2021) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2021.108246 · Cited by 20
Okawa, T., Kamiya, H., Himeno, T., Seino, Y., Tsunekawa, S., Hayashi, Y., Harada, N., Yamada, Y., Inagaki, N., Seino, Y., et al. (2013) · Journal of Diabetes Investigation · doi:10.1111/jdi.12129 · Cited by 18
New Horizons in the Management of Alzheimer Disease
Morley, J. E. (2014) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2014.10.022 · Cited by 18
Kelany, M. E., Hakami, T. M., Omar, A. H., & Abdallah, M. A. (2016) · Pharmacology · doi:10.1159/000448043 · Cited by 18
Acute administration of GLP-1 receptor agonists induces hypolocomotion but not anxiety in mice
Krass, M., Rünkorg, K., Vasar, E., & Volke, V. (2012) · Acta Neuropsychiatrica · doi:10.1111/j.1601-5215.2012.00648.x · Cited by 18
Ma, X., Hui, H., Liu, Z., He, G., Hu, J. R., Meng, J., Guan, L., & Luo, X. (2009) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2009.01070.x · Cited by 18
Bi, Z., Wang, L., & Wang, W. (2023) · Advances in Clinical and Experimental Medicine · doi:10.17219/acem/161734 · Cited by 21
The Role of Essential Fatty Acids in Anorexia Nervosa and Obesity
Yehuda, S., & Rabinovitz, S. (2015) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2013.809690 · Cited by 17
Therapeutic Use of Intranasal Glucagon: Resolution of Hypoglycemia
Pontiroli, A. E., & Tagliabue, E. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20153646 · Cited by 17
Incretin Therapies: Effects Beyond Glycemic Control
Mudaliar, S. R. D., & Henry, R. R. (2009) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2009.05.010 · Cited by 20
Sugiyama, C., Yamamoto, M., Kotani, T., Kikkawa, F., Murata, Y., & Hayashi, Y. (2012) · PLoS ONE · doi:10.1371/journal.pone.0043745 · Cited by 17
Aβ Infusion and Related Models of Alzheimer Dementia
Lawlor, P. A., & Young, D. (2010) · Neuromethods · doi:10.1007/978-1-60761-898-0_17 · Cited by 20
Kobayashi, K., Iwai, T., Sasaki‐Hamada, S., Kamanaka, G., & Oka, J. (2013) · Brain Research · doi:10.1016/j.brainres.2013.01.012 · Cited by 19
Hussein, M. H., Alameen, A. A., Ansari, M. A., AlSharari, S. D., Ahmad, S. F., Attia, M. S. M., Sarawi, W. S., Nadeem, A., Bakheet, S. A., & Attia, S. M. (2024) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2024.111091 · Cited by 18
Involvement of Intestinal Enteroendocrine Cells in Neurological and Psychiatric Disorders
Yu, L.-E., & Li, Y. (2022) · Biomedicines · doi:10.3390/biomedicines10102577 · Cited by 18
Li, J., Liang, X., Alam, M. S., Luo, H., Zhang, Y., Peng, B., Xiao, Q., Zhang, Z., Liu, L., & He, S. (2021) · Journal of Comparative Physiology B · doi:10.1007/s00360-021-01393-7 · Cited by 16
Potential new therapeutic target for Alzheimer's disease: Glucagon‐like peptide‐1
Liu, X., Zhang, N., Zhang, S., & Xu, P. (2021) · European Journal of Neuroscience · doi:10.1111/ejn.15502 · Cited by 17
Endocrine dysfunction and cognitive impairment
Calsolaro, V., Bottari, M., Coppini, G., Lemmi, B., & Monzani, F. (2021) · Minerva Endocrinology · doi:10.23736/s2724-6507.20.03295-2 · Cited by 17
Glage, S., Klinge, P. M., Miller, M. C., Wallrapp, C., Geigle, P., Hedrich, H. J., & Brinker, T. (2011) · Fluids and Barriers of the CNS · doi:10.1186/2045-8118-8-18 · Cited by 16
Day, S. M., Yang, W., Ewin, S. E., Zhou, X., & Ma, T. (2017) · Hippocampus · doi:10.1002/hipo.22795 · Cited by 19
Cao, T., Tang, M., Jiang, P., Zhang, B., Wu, X., Chen, Q., Zeng, C., Li, N., Zhang, S., & Cai, H. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.612083 · Cited by 20
Ram, H., Jaipal, N., Kumar, P., Deka, P., Kumar, S., Kashyap, P., Kumar, S., Singh, B. P., Alqarawi, A. A., Hashem, A., et al. (2019) · Current Alzheimer Research · doi:10.2174/1567205016666191203161509 · Cited by 15
Barakat, G. M., Nuwayri‐Salti, N., Kadi, L., Bitar, K. M., Al-Jaroud, W., & Bikhazi, A. B. (2011) · General Physiology and Biophysics · doi:10.4149/gpb_2011_01_34 · Cited by 15
Commonality between Diabetes and Alzheimer's Disease and a New Strategy for the Therapy
Li, L. (2008) · Clinical Medicine Insights Pathology · doi:10.4137/cpath.s667 · Cited by 15
Medicinal Chemistry of Glucagon-Like Peptide Receptor Agonists
Jones, L. H., & Price, D. A. (2013) · Progress in medicinal chemistry · doi:10.1016/b978-0-444-62652-3.00002-8 · Cited by 19
Tanioka, M., Park, W. K., Shim, I., Kim, K., Choi, S., Kim, U. J., Lee, K. H., Hong, S., & Lee, B. H. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21082706 · Cited by 18
Engineering of smart nanoconstructs for delivery of glucagon-like peptide-1 analogs
Eissa, N. G., Elsabahy, M., & Allam, A. (2021) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2021.120317 · Cited by 17
Khan, N. M., Ahmad, A., Tiwari, R., Kamal, M. A., Mushtaq, G., & Ashraf, G. M. (2014) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527313666141023160448 · Cited by 20
Monar, G. V. F., Cruz, C. S., & Martinez, E. C. (2025) · Journal of Nutrition and Metabolism · doi:10.1155/jnme/5571686 · Cited by 17
Sabbagh, M. N., Cummings, J. L., Ballard, C. G., van der Flier, W. M., Heneka, M. T., Holst, J. J., Knudsen, L. B., Salloway, S., Tansey, M. G., & Drucker, D. J. (2025) · Nature Aging · doi:10.1038/s43587-025-01029-3 · Cited by 17
Self-citationGautier, T., Fahet, N., Tamanai‐Shacoori, Z., Oliviero, N., Blot, M., Sauvager, A., Burel, A., Gall‐David, S. L., Tomasi, S., Blat, S., et al. (2022) · Microorganisms · doi:10.3390/microorganisms10112263 · Cited by 21
GLP-1 receptor agonists as promising disease-modifying agents in WFS1 spectrum disorder
Panfili, E., Frontino, G., & Pallotta, M. T. (2023) · Frontiers in Clinical Diabetes and Healthcare · doi:10.3389/fcdhc.2023.1171091 · Cited by 16
Updates on pharmacological treatment for Alzheimer’s disease
Tipton, P. W. (2024) · Neurologia i Neurochirurgia Polska · doi:10.5603/pjnns.96286 · Cited by 17
Li, H., Shi, M., Ma, J., Shao, S., Yuan, Y., Liu, J., Yu, Z., Zhang, Z., Hölscher, C., & Zhang, Z. (2024) · The Journal of Prevention of Alzheimer s Disease · doi:10.14283/jpad.2024.6 · Cited by 15
Abubakar, M., Nama, L., Ansari, M. M., Ansari, M. M., Bhardwaj, S., Daksh, R., Syamala, K. L. V., Jamadade, M. S., Chhabra, V., Kumar, D., et al. (2024) · Current Topics in Medicinal Chemistry · doi:10.2174/0115680266293416240515075450 · Cited by 19
The early life exposome and autism risk: a role for the maternal microbiome?
Gesù, C. M. D., & Buffington, S. A. (2024) · Gut Microbes · doi:10.1080/19490976.2024.2385117 · Cited by 21
New Horizons—Cognitive Dysfunction Associated With Type 2 Diabetes
Moran, C., Than, S., Callisaya, M. L., Beare, R. J., & Srikanth, V. K. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab797 · Cited by 17
Incretin hormones and beta cell function in chronic pancreatitis.
Knop, F. K. (2010) · PubMed · Cited by 17
Obesity‐Related Hormones in Low‐Income Preschool‐Age Children: Implications for School Readiness
Miller, A. L., Lumeng, C. N.-K., DelProposto, J. L., Florek, B., Wendorf, K., & Lumeng, J. C. (2013) · Mind Brain and Education · doi:10.1111/mbe.12034 · Cited by 18
Neuroenergetics of traumatic brain injury
Karelina, K., & Weil, Z. M. (2015) · Concussion · doi:10.2217/cnc.15.9 · Cited by 15
Zhang, S., Cai, H.-Y., Ma, X., Li, Y., Zhang, J., Wang, Z., Li, Y., & Qi, J. (2017) · Behavioural Brain Research · doi:10.1016/j.bbr.2017.03.018 · Cited by 14
Zhang, H., Song, B., Zhu, W., Liu, L., He, X., Wang, Z., An, K., Cao, W., Shi, J., & Wang, S. (2021) · Aging · doi:10.18632/aging.203351 · Cited by 14
Bednarz, K., & Siuda, J. S. (2021) · Neurologia i Neurochirurgia Polska · doi:10.5603/pjnns.a2021.0056 · Cited by 15
Cardiovascular effects of GLP-1 receptor agonism
Winquist, R. J., & Gribkoff, V. K. (2022) · Advances in pharmacology · doi:10.1016/bs.apha.2022.02.005 · Cited by 16
Metadata
- Authors
- During, M. J., Cao, L., Zuzga, D. S., Francis, J. S., Fitzsimons, H. L., Jiao, X., Bland, R. J., Klugmann, M., Banks, W. A., Drucker, D. J., & Haile, C. N.
- Affiliations
- University of Auckland (NZ)
- Thomas Jefferson University (US)
- St. Louis VA Medical Center (US)
- University of Toronto (CA)
- Corresponding author
- During, Matthew J
- ORCID
- Venue
- Nature Medicine
- Published
- 2003-08-17
- Volume
- 9
- Issue
- 9
- Pages
- 1173-1179
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- OpenAlex
- W2124852816
- Cited by
- 851
- References
- 42
- Citations by year
- 2026: 34 · 2025: 40 · 2024: 50 · 2023: 39 · 2022: 58 · 2021: 53 · 2020: 44 · 2019: 36 · 2018: 37 · 2017: 39 · 2016: 34 · 2015: 54 · 2014: 46 · 2013: 47 · 2012: 43
- FWCI
- 6.81
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Nature Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Marsden Fund
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Keywords
- GLP-1 receptor, glucagon-like peptide-1, associative learning, spatial learning, memory, hippocampus, neuroprotection, kainate-induced seizures, neuronal apoptosis, cognitive enhancement, gut-brain signaling
- MeSH terms
- Glucagon-Like Peptide-1 Receptor, Administration, Intranasal, Amino Acid Sequence, Animals, Behavior, Animal, Cognition, Glucagon, Hippocampus, Kainic Acid, Learning, Male, Molecular Sequence Data, Neurons, Peptide Fragments, Protein Precursors, Seizures, Signal Transduction, Gene Expression, Rats, Sprague-Dawley, Apoptosis, Sequence Homology, Amino Acid, Gene Transfer Techniques, Receptors, Glucagon, Mice, Knockout, Neuroprotective Agents, Mice, Rats, Glucagon-Like Peptide 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.